Umlaut.bio GmbH
PrivateLast Round
Pre Seed
Feb 19, 2026
Total Funding Raised
$3.54M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Umlaut.bio GmbH operates in Healthcare & Life Sciences and is based in Heidelberg. Its latest recorded funding round was a Pre Seed round in February 2026.
Umlaut.bio GmbH is a biotechnology company that develops first-in-biology small molecule therapeutics targeting tRNA modifications to treat cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Umlaut.bio GmbH Comparables
Compare Umlaut.bio GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chemestmed | 84% | |
| O2nix Bio | 79% | |
| Twentyeight-Seven Therapeutics | 77% |
For institutional investors. Book with your work email.
Umlaut.bio GmbH Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Umlaut.bio GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BaseLaunch | Pre Seed |
| High-Tech Gründerfonds | Pre Seed |
| L-Bank | Pre Seed |
| LBBW Venture Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 3965% MoM, reaching 1.1K.
- Apr 3, 2026
Monthly visitors grew 11300% MoM, from 26 to 3K.
For institutional investors. Book with your work email.
Umlaut.bio GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Umlaut.bio GmbH's valuation, stock price, and market status.
Is Umlaut.bio GmbH a public or private company?
Umlaut.bio GmbH is a private company.
What is the current stock price of Umlaut.bio GmbH?
Umlaut.bio GmbH is a private company, so its shares have no public market price. Caplight tracks Umlaut.bio GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Umlaut.bio GmbH worth (valuation)?
Valuation information for Umlaut.bio GmbH is not publicly available.
Can I buy Umlaut.bio GmbH stock?
Umlaut.bio GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Umlaut.bio GmbH's last funding round?
Umlaut.bio GmbH's most recent funding round was Pre Seed on February 19, 2026.
Who are the main investors in Umlaut.bio GmbH?
Key investors in Umlaut.bio GmbH include BaseLaunch, High-Tech Gründerfonds, L-Bank, LBBW Venture Capital.
Will Umlaut.bio GmbH IPO soon?
No public IPO plans have been announced for Umlaut.bio GmbH.
How can I track Umlaut.bio GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Umlaut.bio GmbH's shares on secondary markets.